Emblation Microwave

Emblation is a UK-based medical device company developing and commercializing microwave-based treatment systems for dermatology, podiatry, oncology, and other clinical applications. Its flagship commercial product is the Swift system, which delivers targeted microwave energy for treatment of HPV-related skin lesions such as common and plantar warts. The company also develops higher-power microwave systems for oncology and other specialties, and describes a broader innovation pipeline built around its Microwave Immune-Modulating (IM) technology. Emblation manufactures energy-based medical systems and also supplies OEM microwave generator technologies for healthcare, industrial, and research applications. The business is active internationally, including the UK and US, and has received FDA 510(k) clearance for expanded wart-treatment indications.